Serono workers plot strike, lash out over R&D failures

Whipped into action by the stunning news that Merck KGaA plans to shutter Serono's big Geneva facility, FiercePharma reports that workers are preparing a strike, claiming that the pharma company has been sugarcoating the big layoffs being planned. When it made its initial announcement, the German company said that it planned to transfer 750 workers. But employee groups say that few are willing to take the transfers, as they are being offered "really unattractive" pay packages. And investigators are claiming the company's cumbersome decision-making process has caused poor productivity of recent years. A strike is being threatened for tomorrow. Story

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.